Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.


De Caterina, Raffaele, Procopio, Antonio, Lopez Sendon, Jose-Luis, Raev, Dimitar, Mehta, Shamir R, Opolski, Grzegorz, Oldgren, Jonas, Steg, Philippe Gabriel, Hohnloser, Stefan H, Lip, Gregory YH ORCID: 0000-0002-7566-1626
et al (show 7 more authors) (2020) Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI. AMERICAN JOURNAL OF MEDICINE, 133 (11). pp. 1302-1312.


Oldgren, Jonas, Steg, Philippe Gabriel, Hohnloser, Stefan H, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Kimura, Takeshi, Nordaby, Matias, Brueckmann, Martina, Kleine, Eva, ten Berg, Jurrien M, Bhatt, Deepak L
et al (show 1 more authors) (2019) Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial. EUROPEAN HEART JOURNAL, 40 (19). 1553-+.


Rosencher, Nadia, Samama, Charles M, Feuring, Martin, Brueckmann, Martina, Kleine, Eva, Clemens, Andreas and Frostick, Simon
(2016) Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical setting. Thrombosis Journal, 14 (1).


Peterson, Benjamin E, Bhatt, Deepak L, Steg, Ph Gabriel, Oldgren, Jonas, Maeng, Michael, Zeymer, Uwe, Halvorsen, Sigrun, Hohnloser, Stefan H, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Kimura, Takeshi
et al (show 5 more authors) (2021) Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial. JACC-CARDIOVASCULAR INTERVENTIONS, 14 (7). pp. 768-780.

This list was generated on Mon Feb 12 14:00:56 2024 GMT.